These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2140392)

  • 21. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies.
    Isenman DE
    J Biol Chem; 1983 Apr; 258(7):4238-44. PubMed ID: 6220003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural characterization of factor I mediated cleavage of the third component of complement.
    Davis AE; Harrison RA
    Biochemistry; 1982 Nov; 21(23):5745-9. PubMed ID: 6217832
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulatory system of guinea-pig complement C3b: tests for compatibility of guinea-pig factors H and I with human factors.
    Seya T; Okada M; Hazeki K; Nagasawa S
    Mol Immunol; 1991; 28(4-5):375-82. PubMed ID: 1829503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V; Wessberg S; Leikola J
    Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
    Haque A; Cortes C; Alam MN; Sreedhar M; Ferreira VP; Pangburn MK
    Front Immunol; 2020; 11():1728. PubMed ID: 32849614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor C3f is a spasmogenic fragment released from C3b by factors I and H: the heptadeca-peptide C3f was synthesized and characterized.
    Ganu VS; Müller-Eberhard HJ; Hugli TE
    Mol Immunol; 1989 Oct; 26(10):939-48. PubMed ID: 2531841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C; Kingzette M; Gewurz H
    J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies Against C3b-Functional Consequences and Disease Relevance.
    Vasilev VV; Radanova M; Lazarov VJ; Dragon-Durey MA; Fremeaux-Bacchi V; Roumenina LT
    Front Immunol; 2019; 10():64. PubMed ID: 30761135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
    Hannan JP; Laskowski J; Thurman JM; Hageman GS; Holers VM
    PLoS One; 2016; 11(11):e0166200. PubMed ID: 27814381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b.
    Meuth JL; Morgan EL; DiSipio RG; Hugli TE
    J Immunol; 1983 Jun; 130(6):2605-11. PubMed ID: 6602172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S; Pangburn MK
    Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
    Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
    J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME; Iida K; Mold C; Nussenzweig V
    J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.
    Koistinen V
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):255-9. PubMed ID: 1835839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of a 33,000-dalton fragment of complement Factor B with catalytic and C3b binding activity.
    Lambris JD; Müller-Eberhard HJ
    J Biol Chem; 1984 Oct; 259(20):12685-90. PubMed ID: 6567645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
    Pangburn MK
    J Immunol; 1989 Apr; 142(8):2759-65. PubMed ID: 2467938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.
    Seya T; Okada M; Nishino H; Atkinson JP
    J Biochem; 1990 Feb; 107(2):310-5. PubMed ID: 2141838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.